Basic Information

Gene symbol tk

GTO ID GTC0623
Trial ID 2009-012973-37
Disease Acute Leukemia
Altered gene tk
Therapeutic/Target gene Therapeutic gene
TherapyGene transfer
Treatment HSV-TK transduced T cells
PhasePhase3
Recruitment statusPrematurely Ended
TitleTK008: Randomized phase III trial of haploidentical HCT with or without an add back strategy of HSV-Tk donor lymphocytes in patients with high risk acute leukemia
Year2009
CountryItaly
Company sponsorMOLMED

Clinical Result

Cohort 1
Administration route intravenous infusion
Dosage 500 mg
Donor type Allogeneic
Age Adult, Older_Adult

Relationship Graph

Overview of Knowledge Graph